Abstract
The core of translational research (TR) is the idea of "bench-to-bedside", establishing achievements of basic research through clinical applications. TR revolutionizes the current drug development process in Japan, encouraging faster and more cost-effective drug development, transforming the R&D organizations, and fostering bio-venture companies. TR is a powerful process in reviving the international competitiveness of domestic pharmaceutical companies.